All Stories

  1. Role of Non-coding RNAs on the Radiotherapy Sensitivity and Resistance in Cancer Cells

    Article • Current Gene Therapy, April 2025, Bentham Science Publishers

    Soghra Farzipour

  2. Nanotechnology Utilizing Ferroptosis Inducers in Cancer Treatment

    Article • Anti-Cancer Agents in Medicinal Chemistry, May 2024, Bentham Science Publishers

    zahra shaghaghi, Saeed Bahadorikhalili, Soghra Farzipour

  3. Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy

    Article • Current Radiopharmaceuticals, March 2024, Bentham Science Publishers

    Soghra Farzipour, zahra shaghaghi

  4. Targeting Ferroptosis as a New Approach for Radiation Protection and Mitigation

    Article • Recent Patents on Anti-Cancer Drug Discovery, February 2024, Bentham Science Publishers

    zahra shaghaghi, Soghra Farzipour

  5. Evaluation of the Effect of Chelating Arms and Carrier Agents on t he Radiotoxicity of TAT Agents

    Article • Current Radiopharmaceuticals, March 2023, Bentham Science Publishers

    Soghra Farzipour, zahra shaghaghi

  6. Radioprotective Effect of Febuxostat Against Testicular Damage Induced by Ionizing Radiation in Mice

    Article • Current Radiopharmaceuticals, June 2022, Bentham Science Publishers

    Soghra Farzipour, Seyed Jalal HOSSEINIMEHR

  7. Recent Achievements about Targeted Alpha Therapy-Based Targeting Vectors and Chelating Agents

    Article • Anti-Cancer Agents in Medicinal Chemistry, May 2022, Bentham Science Publishers

    Soghra Farzipour, zahra shaghaghi

  8. The Radiosensitizing Effect of Olanzapine as an Antipsychotic Medication on Glioblastoma Cell

    Article • Current Radiopharmaceuticals, March 2022, Bentham Science Publishers

    Seyed Jalal HOSSEINIMEHR, Soghra Farzipour

  9. Correlation between in vitro and in vivo Data of Radiolabeled Peptide for Tumor Targeting

    Article • Mini-Reviews in Medicinal Chemistry, July 2019, Bentham Science Publishers

    Seyed Jalal HOSSEINIMEHR, Soghra Farzipour